MDS/MPN-U and CMML patients frequently carried mutations in epigenetic regulators (ASXL1, TET2) and RNA splicing genes (SF3B1, SRSF2, ZRSR2). The gene discussed is SF3B1; the disease is myeloproliferative neoplasm, unclassifiable.